Friday, September 14, 2018

Lupin gets USFDA approval

Image result for lupin


Lupin  has received approval from the US Food and Drug Administration to market its Atovaquone oral suspension in the strength of 750 mg/5 mL. The product is a generic version of GlaxoSmithKline's Mepron oral suspension in the same strength.

No comments:

Post a Comment